Description
Waystar Unleashes Game-Changing Cross-Sell Power—Can The Management Up Its Game In Healthcare Tech?
Waystar’s third-quarter 2025 financial results highlight both opportunities and challenges as the company continues its mission to modernize the healthcare payment process through its AI-powered, cloud-based platform. The company demonstrated significant growth, with revenue reaching $269 million, a 12% increase year-over-year, and an adjusted EBITDA margin of 42%. This performance surpasses its guidance, suggesting effective execution and strong client retention and expansion. One of the strategic focal points for Waystar is the completed acquisition of Iodine Software, which is positioned to enhance its offering by integrating clinical, financial, administrative, and payer data. Iodine expands Waystar’s total addressable market by more than 15% and brings about 150 new health systems into its client base. This acquisition is expected to accelerate portions of Waystar’s product roadmap by nearly two years, enhancing capabilities in areas such as clinical documentation integrity and utilization management.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
